Is a 4-month regimen adequate to cure patients with non-cavitary tuberculosis and negative cultures at 2 months?

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 6, 2013, Pages 807-809

  Phillips, Patrick P J ^a   Nunn, A J ^a   Paton, N I ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomarkers; Cavitation; Clinical trials; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

AFRICA; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; NONCAVITARY LUNG TUBERCULOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RETROSPECTIVE STUDY; SINGAPORE; TREATMENT DURATION;

ADULT; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84878337961     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0725     Document Type: Article

References (12)

1. Fox W. Whither short-course chemotherapy? Br J Dis Chest 1981; 75: 331-357. (Pubitemid 11018322)
2. Zumla A, Hafner R, Lienhardt C, Hoelscher M, Nunn A. Advancing the development of tuberculosis therapy. Nat Rev Drug Discov 2012; 11: 171-172.
3. Johnson J L, Hadad D J, Dietze R, et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med 2009; 180: 558-563.
4. Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119: 579-585.
5. Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months. Tubercle 1981; 62: 95-102.
6. Singapore Tuberculosis Service/British Medical Research Council. Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 779-783.
7. East African/British Medical Research Council. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. Lancet 1978; 2: 334-338.
8. East African/British Medical Research Council. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study. Am Rev Respir Dis 1981; 123: 165-170.
9. Simon G. Radiology in epidemiological studies and some therapeutic trials. Br Med J 1966; 2: 491.
10. Agresti A, Caffo B. Simple and effective confidence intervals for proportions and differences of proportions result from adding two successes and two failures. American Statistician 2000; 54: 280-288. (Pubitemid 33204723)
11. Brown L D, Cai T T, DasGupta A. Interval estimation for a binomial proportion. Rejoinder. Stat Sci 2001; 16: 128-133.
12. East and Central African/British Medical Research Council. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Tubercle 1983; 64: 153-166.